Trials / Terminated
TerminatedNCT02679248
A Study to Investigate the Effect of a Nitric Oxide Supplementation on Pre- and Mildly Hypertensive Adults
A Double Blind, Placebo Controlled Parallel Study to Investigate the Effect of a Nitric Oxide Supplementation Product on Pre- and Mildly Hypertensive Adults.
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 67 (actual)
- Sponsor
- KGK Science Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will investigate the effect of a nitric oxide supplementation product, Neo40 Daily®, on blood pressure in pre-hypertensive and mildly hypertensive adults. Subjects will take 2 lozenges per day 12 hours apart for 8 weeks. Half of the subjects will receive Neo40 Daily® and the other half of the subjects will receive placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Neo40 Daily® | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2016-02-03
- Primary completion
- 2017-02-03
- Completion
- 2017-03-01
- First posted
- 2016-02-10
- Last updated
- 2018-04-12
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02679248. Inclusion in this directory is not an endorsement.